APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ovarian Cancer Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ovarian Cancer Treatment Drugs Industry Growth and Trends Forecast to 2032

22 December 202598 pages

Choose your research edition.

Industry ResearchOvarian Cancer Treatment Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Ovarian Cancer Treatment Drugs Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Ovarian Cancer Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ovarian Cancer Treatment Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Ovarian Cancer Treatment Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Ovarian Cancer Treatment Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ovarian Cancer Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ovarian Cancer Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ovarian Cancer Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ovarian Cancer Treatment Drugs include Roche, AstraZeneca, Tesaro, Polaris Pharma, Kazia Therapeutics and Clovis Oncology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ovarian Cancer Treatment Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ovarian Cancer Treatment Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ovarian Cancer Treatment Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ovarian Cancer Treatment Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ovarian Cancer Treatment Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ovarian Cancer Treatment Drugs Market by Company

Roche

AstraZeneca

Tesaro

Polaris Pharma

Kazia Therapeutics

Clovis Oncology

Ovarian Cancer Treatment Drugs Segment by Type

Small Molecules Drug

Therapertic Antibody

Anti-estrogens

Fluoropyrimidines

Aromatase Inhibitors (Endocrine Therapy Drug)

Aromatase Inhibitors (Targeted Therapy Drug)

Anthracycline Antibiotics

Platinum Anticancer Drugs

Ovarian Cancer Treatment Drugs Segment by Application

Clinic

Hospital

Drugstore

Others

Ovarian Cancer Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ovarian Cancer Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ovarian Cancer Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ovarian Cancer Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ovarian Cancer Treatment Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ovarian Cancer Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Small Molecules Drug Table 2. Major Company of Therapertic Antibody Table 3. Major Company of Anti-estrogens Table 4. Major Company of Fluoropyrimidines Table 5. Major Company of Aromatase Inhibitors (Endocrine Therapy Drug) Table 6. Major Company of Aromatase Inhibitors (Targeted Therapy Drug) Table 7. Major Company of Anthracycline Antibiotics Table 8. Major Company of Platinum Anticancer Drugs Table 9. Global Ovarian Cancer Treatment Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 10. Global Ovarian Cancer Treatment Drugs Sales by Type (2021-2026) & (k units) Table 11. Global Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Type (2021-2026) Table 12. Global Ovarian Cancer Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 13. Global Ovarian Cancer Treatment Drugs Sales Market Share in Value by Type (2021-2026) Table 14. Global Ovarian Cancer Treatment Drugs Price by Type (2021-2026) & (US$/unit) Table 15. Global Ovarian Cancer Treatment Drugs Sales by Type (2027-2032) & (k units) Table 16. Global Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Type (2027-2032) Table 17. Global Ovarian Cancer Treatment Drugs Sales by Type (2027-2032) & (US$ Million) Table 18. Global Ovarian Cancer Treatment Drugs Sales Market Share in Value by Type (2027-2032) Table 19. Global Ovarian Cancer Treatment Drugs Price by Type (2027-2032) & (US$/unit) Table 20. North America Ovarian Cancer Treatment Drugs Sales by Type (2021-2026) & (k units) Table 21. North America Ovarian Cancer Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Europe Ovarian Cancer Treatment Drugs Sales by Type (2021-2026) & (k units) Table 23. Europe Ovarian Cancer Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Asia-Pacific Ovarian Cancer Treatment Drugs Sales by Type (2021-2026) & (k units) Table 25. Asia-Pacific Ovarian Cancer Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Latin America Ovarian Cancer Treatment Drugs Sales by Type (2021-2026) & (k units) Table 27. Latin America Ovarian Cancer Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. Middle East and Africa Ovarian Cancer Treatment Drugs Sales by Type (2021-2026) & (k units) Table 29. Middle East and Africa Ovarian Cancer Treatment Drugs Sales by Type (2021-2026) & (US$ Million) Table 30. Ovarian Cancer Treatment Drugs Industry Trends Table 31. Ovarian Cancer Treatment Drugs Industry Drivers Table 32. Ovarian Cancer Treatment Drugs Industry Opportunities and Challenges Table 33. Ovarian Cancer Treatment Drugs Industry Restraints Table 34. Global Ovarian Cancer Treatment Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 35. Global Ovarian Cancer Treatment Drugs Revenue Market Share by Company (2021-2026) Table 36. Global Ovarian Cancer Treatment Drugs Sales by Company (2021-2026) & (k units) Table 37. Global Ovarian Cancer Treatment Drugs Sales Share by Company (2021-2026) Table 38. Global Ovarian Cancer Treatment Drugs Market Price by Company (2021-2026) & (US$/unit) Table 39. Global Ovarian Cancer Treatment Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 40. Global Ovarian Cancer Treatment Drugs Major Company Production Sites and Headquarters Table 41. Global Ovarian Cancer Treatment Drugs Company, Product Type & Application Table 42. Global Ovarian Cancer Treatment Drugs Company Establishment Date Table 43. Global Company Market Concentration Ratio (CR5 and HHI) Table 44. Global Ovarian Cancer Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 45. Global Ovarian Cancer Treatment Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 46. Global Ovarian Cancer Treatment Drugs Sales by Region (2021-2026) & (k units) Table 47. Global Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Region (2021-2026) Table 48. Global Ovarian Cancer Treatment Drugs Sales by Region (2021-2026) & (US$ Million) Table 49. Global Ovarian Cancer Treatment Drugs Sales Market Share in Value by Region (2021-2026) Table 50. Global Ovarian Cancer Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Global Ovarian Cancer Treatment Drugs Sales by Region (2027-2032) & (k units) Table 52. Global Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Region (2027-2032) Table 53. Global Ovarian Cancer Treatment Drugs Sales by Region (2027-2032) & (US$ Million) Table 54. Global Ovarian Cancer Treatment Drugs Sales Market Share in Value by Region (2027-2032) Table 55. Global Ovarian Cancer Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 56. Global Ovarian Cancer Treatment Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 57. Global Ovarian Cancer Treatment Drugs Sales by Application (2021-2026) & (k units) Table 58. Global Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Application (2021-2026) Table 59. Global Ovarian Cancer Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 60. Global Ovarian Cancer Treatment Drugs Sales Market Share in Value by Application (2021-2026) Table 61. Global Ovarian Cancer Treatment Drugs Price by Application (2021-2026) & (US$/unit) Table 62. Global Ovarian Cancer Treatment Drugs Sales by Application (2027-2032) & (k units) Table 63. Global Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Application (2027-2032) Table 64. Global Ovarian Cancer Treatment Drugs Sales by Application (2027-2032) & (US$ Million) Table 65. Global Ovarian Cancer Treatment Drugs Sales Market Share in Value by Application (2027-2032) Table 66. Global Ovarian Cancer Treatment Drugs Price by Application (2027-2032) & (US$/unit) Table 67. North America Ovarian Cancer Treatment Drugs Sales by Application (2021-2026) & (k units) Table 68. North America Ovarian Cancer Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Europe Ovarian Cancer Treatment Drugs Sales by Application (2021-2026) & (k units) Table 70. Europe Ovarian Cancer Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Asia-Pacific Ovarian Cancer Treatment Drugs Sales by Application (2021-2026) & (k units) Table 72. Asia-Pacific Ovarian Cancer Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Latin America Ovarian Cancer Treatment Drugs Sales by Application (2021-2026) & (k units) Table 74. Latin America Ovarian Cancer Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. Middle East and Africa Ovarian Cancer Treatment Drugs Sales by Application (2021-2026) & (k units) Table 76. Middle East and Africa Ovarian Cancer Treatment Drugs Sales by Application (2021-2026) & (US$ Million) Table 77. Roche Company Information Table 78. Roche Business Overview Table 79. Roche Ovarian Cancer Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Roche Ovarian Cancer Treatment Drugs Product Portfolio Table 81. Roche Recent Development Table 82. AstraZeneca Company Information Table 83. AstraZeneca Business Overview Table 84. AstraZeneca Ovarian Cancer Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. AstraZeneca Ovarian Cancer Treatment Drugs Product Portfolio Table 86. AstraZeneca Recent Development Table 87. Tesaro Company Information Table 88. Tesaro Business Overview Table 89. Tesaro Ovarian Cancer Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Tesaro Ovarian Cancer Treatment Drugs Product Portfolio Table 91. Tesaro Recent Development Table 92. Polaris Pharma Company Information Table 93. Polaris Pharma Business Overview Table 94. Polaris Pharma Ovarian Cancer Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Polaris Pharma Ovarian Cancer Treatment Drugs Product Portfolio Table 96. Polaris Pharma Recent Development Table 97. Kazia Therapeutics Company Information Table 98. Kazia Therapeutics Business Overview Table 99. Kazia Therapeutics Ovarian Cancer Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Kazia Therapeutics Ovarian Cancer Treatment Drugs Product Portfolio Table 101. Kazia Therapeutics Recent Development Table 102. Clovis Oncology Company Information Table 103. Clovis Oncology Business Overview Table 104. Clovis Oncology Ovarian Cancer Treatment Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Clovis Oncology Ovarian Cancer Treatment Drugs Product Portfolio Table 106. Clovis Oncology Recent Development Table 107. North America Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 108. North America Ovarian Cancer Treatment Drugs Sales by Country (2021-2026) & (k units) Table 109. North America Ovarian Cancer Treatment Drugs Sales Market Share by Country (2021-2026) Table 110. North America Ovarian Cancer Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 111. North America Ovarian Cancer Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 112. North America Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Ovarian Cancer Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Ovarian Cancer Treatment Drugs Market Share by Country (2021-2026) Table 115. North America Ovarian Cancer Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Ovarian Cancer Treatment Drugs Market Share Forecast by Country (2027-2032) Table 117. Europe Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 118. Europe Ovarian Cancer Treatment Drugs Sales by Country (2021-2026) & (k units) Table 119. Europe Ovarian Cancer Treatment Drugs Sales Market Share by Country (2021-2026) Table 120. Europe Ovarian Cancer Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 121. Europe Ovarian Cancer Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Ovarian Cancer Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Ovarian Cancer Treatment Drugs Market Share by Country (2021-2026) Table 125. Europe Ovarian Cancer Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Ovarian Cancer Treatment Drugs Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Ovarian Cancer Treatment Drugs Sales by Country (2021-2026) & (k units) Table 129. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 131. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Ovarian Cancer Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Ovarian Cancer Treatment Drugs Market Share by Country (2021-2026) Table 135. Asia-Pacific Ovarian Cancer Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Ovarian Cancer Treatment Drugs Market Share Forecast by Country (2027-2032) Table 137. Latin America Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Latin America Ovarian Cancer Treatment Drugs Sales by Country (2021-2026) & (k units) Table 139. Latin America Ovarian Cancer Treatment Drugs Sales Market Share by Country (2021-2026) Table 140. Latin America Ovarian Cancer Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 141. Latin America Ovarian Cancer Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Ovarian Cancer Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Ovarian Cancer Treatment Drugs Market Share by Country (2021-2026) Table 145. Latin America Ovarian Cancer Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Ovarian Cancer Treatment Drugs Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Ovarian Cancer Treatment Drugs Sales by Country (2021-2026) & (k units) Table 149. Middle East and Africa Ovarian Cancer Treatment Drugs Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Ovarian Cancer Treatment Drugs Sales Forecast by Country (2027-2032) & (k units) Table 151. Middle East and Africa Ovarian Cancer Treatment Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Ovarian Cancer Treatment Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Ovarian Cancer Treatment Drugs Market Share by Country (2021-2026) Table 155. Middle East and Africa Ovarian Cancer Treatment Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Ovarian Cancer Treatment Drugs Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Ovarian Cancer Treatment Drugs Distributors List Table 160. Ovarian Cancer Treatment Drugs Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Ovarian Cancer Treatment Drugs Image Figure 2. Global Ovarian Cancer Treatment Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ovarian Cancer Treatment Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Ovarian Cancer Treatment Drugs Sales (2021-2032) & (k units) Figure 5. Small Molecules Drug Image Figure 6. Global Small Molecules Drug Sales YoY Growth (2021-2032) & (k units) Figure 7. Therapertic Antibody Image Figure 8. Global Therapertic Antibody Sales YoY Growth (2021-2032) & (k units) Figure 9. Anti-estrogens Image Figure 10. Global Anti-estrogens Sales YoY Growth (2021-2032) & (k units) Figure 11. Fluoropyrimidines Image Figure 12. Global Fluoropyrimidines Sales YoY Growth (2021-2032) & (k units) Figure 13. Aromatase Inhibitors (Endocrine Therapy Drug) Image Figure 14. Global Aromatase Inhibitors (Endocrine Therapy Drug) Sales YoY Growth (2021-2032) & (k units) Figure 15. Aromatase Inhibitors (Targeted Therapy Drug) Image Figure 16. Global Aromatase Inhibitors (Targeted Therapy Drug) Sales YoY Growth (2021-2032) & (k units) Figure 17. Anthracycline Antibiotics Image Figure 18. Global Anthracycline Antibiotics Sales YoY Growth (2021-2032) & (k units) Figure 19. Platinum Anticancer Drugs Image Figure 20. Global Platinum Anticancer Drugs Sales YoY Growth (2021-2032) & (k units) Figure 21. Global Ovarian Cancer Treatment Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 22. Global Ovarian Cancer Treatment Drugs Market Share by Type 2025 VS 2032 Figure 23. North America Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 24. North America Ovarian Cancer Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 25. Europe Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Europe Ovarian Cancer Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 27. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 29. Latin America Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 30. Latin America Ovarian Cancer Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 31. Middle East and Africa Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Type in 2025 Figure 32. Middle East and Africa Ovarian Cancer Treatment Drugs Sales Market Share in Value by Type in 2025 Figure 33. Global Top 5 and 10 Ovarian Cancer Treatment Drugs Players Market Share by Revenue in 2025 Figure 34. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 35. Clinic Image Figure 36. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 37. Hospital Image Figure 38. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 39. Drugstore Image Figure 40. Global Drugstore Sales YoY Growth (2021-2032) & (k units) Figure 41. Others Image Figure 42. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 43. Global Ovarian Cancer Treatment Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Ovarian Cancer Treatment Drugs Market Share by Application 2025 VS 2032 Figure 45. North America Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 46. North America Ovarian Cancer Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 47. Europe Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Europe Ovarian Cancer Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 49. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 51. Latin America Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 52. Latin America Ovarian Cancer Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 53. Middle East and Africa Ovarian Cancer Treatment Drugs Sales Market Share in Volume by Application in 2025 Figure 54. Middle East and Africa Ovarian Cancer Treatment Drugs Sales Market Share in Value by Application in 2025 Figure 55. North America Ovarian Cancer Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. North America Ovarian Cancer Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. North America Ovarian Cancer Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. North America Ovarian Cancer Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Ovarian Cancer Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Europe Ovarian Cancer Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Ovarian Cancer Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Europe Ovarian Cancer Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Ovarian Cancer Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Asia-Pacific Ovarian Cancer Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Ovarian Cancer Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Asia-Pacific Ovarian Cancer Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Ovarian Cancer Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 68. Latin America Ovarian Cancer Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Ovarian Cancer Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America Ovarian Cancer Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Ovarian Cancer Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 72. Middle East and Africa Ovarian Cancer Treatment Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Ovarian Cancer Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Middle East and Africa Ovarian Cancer Treatment Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Ovarian Cancer Treatment Drugs Value Chain Figure 76. Key Raw Materials Price Figure 77. Manufacturing Cost Structure Figure 78. Ovarian Cancer Treatment Drugs Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • Small Molecules Drug
  • Therapertic Antibody
  • Anti-estrogens
  • Fluoropyrimidines
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Anthracycline Antibiotics
  • Platinum Anticancer Drugs
Applications
  • Clinic
  • Hospital
  • Drugstore
  • Others
Companies covered
  • Roche
  • AstraZeneca
  • Tesaro
  • Polaris Pharma
  • Kazia Therapeutics
  • Clovis Oncology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ovarian Cancer Treatment Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ovarian Cancer Treatment Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ovarian Cancer Treatment Drugs Market by Type
  6. 1.3.1 Small Molecules Drug
  7. 1.3.2 Therapertic Antibody
  8. 1.3.3 Anti-estrogens
  9. 1.3.4 Fluoropyrimidines
  10. 1.3.5 Aromatase Inhibitors (Endocrine Therapy Drug)
  11. 1.3.6 Aromatase Inhibitors (Targeted Therapy Drug)
  12. 1.3.7 Anthracycline Antibiotics
  13. 1.3.8 Platinum Anticancer Drugs
  14. 1.4 Global Ovarian Cancer Treatment Drugs Market Size by Type
  15. 1.4.1 Global Ovarian Cancer Treatment Drugs Market Size Overview by Type (2021-2032)
  16. 1.4.2 Global Ovarian Cancer Treatment Drugs Historic Market Size Review by Type (2021-2026)
  17. 1.4.3 Global Ovarian Cancer Treatment Drugs Forecasted Market Size by Type (2027-2032)
  18. 1.5 Key Regions Market Size by Type
  19. 1.5.1 North America Ovarian Cancer Treatment Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.2 Europe Ovarian Cancer Treatment Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.3 Asia-Pacific Ovarian Cancer Treatment Drugs Sales Breakdown by Type (2021-2026)
  22. 1.5.4 South America Ovarian Cancer Treatment Drugs Sales Breakdown by Type (2021-2026)
  23. 1.5.5 Middle East and Africa Ovarian Cancer Treatment Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ovarian Cancer Treatment Drugs Industry Trends
  2. 2.2 Ovarian Cancer Treatment Drugs Industry Drivers
  3. 2.3 Ovarian Cancer Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Ovarian Cancer Treatment Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ovarian Cancer Treatment Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Ovarian Cancer Treatment Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Ovarian Cancer Treatment Drugs Price (2021-2026)
  4. 3.4 Global Ovarian Cancer Treatment Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ovarian Cancer Treatment Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Ovarian Cancer Treatment Drugs Company, Product Type & Application
  7. 3.7 Global Ovarian Cancer Treatment Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ovarian Cancer Treatment Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ovarian Cancer Treatment Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ovarian Cancer Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Ovarian Cancer Treatment Drugs Regional Status and Outlook
  1. 4.1 Global Ovarian Cancer Treatment Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ovarian Cancer Treatment Drugs Historic Market Size by Region
  3. 4.2.1 Global Ovarian Cancer Treatment Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ovarian Cancer Treatment Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ovarian Cancer Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ovarian Cancer Treatment Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Ovarian Cancer Treatment Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ovarian Cancer Treatment Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ovarian Cancer Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ovarian Cancer Treatment Drugs by Application
  1. 5.1 Ovarian Cancer Treatment Drugs Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Drugstore
  5. 5.1.4 Others
  6. 5.2 Global Ovarian Cancer Treatment Drugs Market Size by Application
  7. 5.2.1 Global Ovarian Cancer Treatment Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Ovarian Cancer Treatment Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Ovarian Cancer Treatment Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Ovarian Cancer Treatment Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Ovarian Cancer Treatment Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Ovarian Cancer Treatment Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Ovarian Cancer Treatment Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Ovarian Cancer Treatment Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Ovarian Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Roche Ovarian Cancer Treatment Drugs Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 AstraZeneca
  8. 6.2.1 AstraZeneca Company Information
  9. 6.2.2 AstraZeneca Business Overview
  10. 6.2.3 AstraZeneca Ovarian Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AstraZeneca Ovarian Cancer Treatment Drugs Product Portfolio
  12. 6.2.5 AstraZeneca Recent Developments
  13. 6.3 Tesaro
  14. 6.3.1 Tesaro Company Information
  15. 6.3.2 Tesaro Business Overview
  16. 6.3.3 Tesaro Ovarian Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tesaro Ovarian Cancer Treatment Drugs Product Portfolio
  18. 6.3.5 Tesaro Recent Developments
  19. 6.4 Polaris Pharma
  20. 6.4.1 Polaris Pharma Company Information
  21. 6.4.2 Polaris Pharma Business Overview
  22. 6.4.3 Polaris Pharma Ovarian Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Polaris Pharma Ovarian Cancer Treatment Drugs Product Portfolio
  24. 6.4.5 Polaris Pharma Recent Developments
  25. 6.5 Kazia Therapeutics
  26. 6.5.1 Kazia Therapeutics Company Information
  27. 6.5.2 Kazia Therapeutics Business Overview
  28. 6.5.3 Kazia Therapeutics Ovarian Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kazia Therapeutics Ovarian Cancer Treatment Drugs Product Portfolio
  30. 6.5.5 Kazia Therapeutics Recent Developments
  31. 6.6 Clovis Oncology
  32. 6.6.1 Clovis Oncology Company Information
  33. 6.6.2 Clovis Oncology Business Overview
  34. 6.6.3 Clovis Oncology Ovarian Cancer Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Clovis Oncology Ovarian Cancer Treatment Drugs Product Portfolio
  36. 6.6.5 Clovis Oncology Recent Developments
7 North America by Country
  1. 7.1 North America Ovarian Cancer Treatment Drugs Sales by Country
  2. 7.1.1 North America Ovarian Cancer Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ovarian Cancer Treatment Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Ovarian Cancer Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ovarian Cancer Treatment Drugs Market Size by Country
  6. 7.2.1 North America Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ovarian Cancer Treatment Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Ovarian Cancer Treatment Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ovarian Cancer Treatment Drugs Sales by Country
  2. 8.1.1 Europe Ovarian Cancer Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ovarian Cancer Treatment Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Ovarian Cancer Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ovarian Cancer Treatment Drugs Market Size by Country
  6. 8.2.1 Europe Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ovarian Cancer Treatment Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ovarian Cancer Treatment Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ovarian Cancer Treatment Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Ovarian Cancer Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ovarian Cancer Treatment Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ovarian Cancer Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ovarian Cancer Treatment Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ovarian Cancer Treatment Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ovarian Cancer Treatment Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ovarian Cancer Treatment Drugs Sales by Country
  2. 10.1.1 South America Ovarian Cancer Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ovarian Cancer Treatment Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Ovarian Cancer Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ovarian Cancer Treatment Drugs Market Size by Country
  6. 10.2.1 South America Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ovarian Cancer Treatment Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Ovarian Cancer Treatment Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ovarian Cancer Treatment Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Ovarian Cancer Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ovarian Cancer Treatment Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ovarian Cancer Treatment Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ovarian Cancer Treatment Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Ovarian Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ovarian Cancer Treatment Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ovarian Cancer Treatment Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ovarian Cancer Treatment Drugs Value Chain Analysis
  2. 12.1.1 Ovarian Cancer Treatment Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ovarian Cancer Treatment Drugs Production Mode & Process
  7. 12.2 Ovarian Cancer Treatment Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ovarian Cancer Treatment Drugs Distributors
  10. 12.2.3 Ovarian Cancer Treatment Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst